Healthcare
Filter News
Found 20,055 articles
-
Santen’s Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States
5/2/2022
Santen’s Verkazia ® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States.
-
AAOS Commits $1M in Grants to Fuel Diversity, Equity, Access and Inclusion Projects Across Orthopaedics
5/2/2022
The American Academy of Orthopaedic Surgeons announced the creation of the AAOS IDEA Grant Program, a multi-year initiative to inspire diversity, equity and access across the field of orthopaedics.
-
Passage Bio to Present Updated Imagine-1 Study Clinical and Biomarker Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
5/2/2022
Passage Bio, Inc. announced that additional clinical and biomarker data from Cohort 1 in the Imagine-1 study for GM1 gangliosidosis will be presented at the upcoming American Society of Gene and Cell Therapy 25th Annual Meeting, which is being held in Washington D.C. and virtually from May 16 to 19, 2022.
-
Xtant Medical Appoints Scott Neils as Chief Financial Officer
5/2/2022
Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the appointment of Scott Neils as Chief Financial Officer, effective June 1, 2022.
-
BrainStorm to Announce First Quarter 2022 Financial Results and Provide a Corporate Update
5/2/2022
BrainStorm Cell Therapeutics Inc. announced that the Company will hold a conference call to update shareholders on financial results for the first quarter ended March 31, 2022, and provide a corporate update, at 8:00 a.m. Eastern Time on May 16, 2022.
-
Extended SpagoPix Patent Protection in USA
5/2/2022
Spago Nanomedical AB has received notice from the United States Patent and Trademark Office that it intends to grant the company's patent application including a critical component of the SpagoPix candidate drug SN132D.
-
uniQure Announces Multiple Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
5/2/2022
uniQure N.V. announced that six data presentations, including one oral presentation, will be delivered at the American Society of Gene and Cell Therapy Hybrid Congress 2022 Annual Meeting being held May 16-19 in Washington, D.C.
-
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 02, 2022
5/2/2022
ImmunoGen, Inc. announced that on April 29, 2022, the compensation committee of the Company’s Board of Directors approved grants of non-qualified stock option awards to purchase an aggregate of 729,530 shares of its common stock to sixteen new employees under the ImmunoGen, Inc.
-
Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
5/2/2022
Johnson & Johnson will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York Hilton Midtown in New York.
-
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 02, 2022
5/2/2022
TCR2 Therapeutics Inc. announced that on April 29, 2022, the Compensation Committee of the Board of Directors of TCR2’s approved the grant of inducement stock options covering an aggregate of 57,200 shares of TCR2’s common stock to 4 new non-executive employees.
-
American Skin Association Announces 2022 Research Grants For Skin Cancer And Diseases
5/2/2022
American Skin Association has announced the names of the two awardees receiving the coveted research grant under the ASA Milstein Research Scholar Awards program.
-
Nicox at ARVO 2022: Presentation of clinical Phase 2 results on NCX 4251 and new non-clinical evidence of improved hemodynamic and retinal cell physiology on NCX 470
5/2/2022
Nicox SA announced poster presentations highlighting the effect of NCX 4251 in patients with dry eye disease as well as new non-clinical evidence of neuroprotective activity on NCX 470 at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting, one of the key scientific events in vision research, being held in person on May 1-4, 2022 in Denver, CO, United States and virtually on May 11-12.
-
IDEAYA Biosciences Receives Orphan Drug Designation for Darovasertib, a PKC Inhibitor, for the Treatment of Uveal Melanoma
5/2/2022
IDEAYA Biosciences, Inc. announced that the U.S. Food and Drug Administration has granted orphan-drug designation to darovasertib, a potential first-in-class protein kinase C inhibitor, for the treatment of uveal melanoma.
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 02, 2022
5/2/2022
Cullinan Oncology, Inc. announced that the compensation committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 207,000 shares of its common stock to two employees outside Cullinan Oncology, Inc’s 2021 Stock Option and Incentive Plan.
-
Researchers from Zhejiang University in China developed an artificially intelligent olfactory system for the diagnosis of Parkinson's disease. An “e-nose” was built to “smell” samples from patients.
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 29, 2022
4/29/2022
Sarepta Therapeutics, Inc. granted equity awards on April 29, 2022 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 44 individuals hired by Sarepta in April 2022.
-
Aravive Announces Poster Presentations at the 2022 ASCO Annual Meeting
4/29/2022
Aravive, Inc. announced the presentation of two poster abstracts at the upcoming American Society of Clinical Oncology 2022 Annual Meeting, to be held in-person on June 3-7, 2022 in Chicago, Illinois.
-
Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting
4/29/2022
Transcenta Holding Limited announces that the abstracts of TST001 and MSB0254 have been accepted by the 2022 annual meeting of American Society of Clinical Oncology.
-
Kroger Health Reduces Barriers to COVID-19 Treatment Options Nationwide
4/29/2022
Kroger Health, the healthcare division of The Kroger Co. Family of Companies, urges Americans to remain diligent in seeking proper testing and care for COVID-19.
-
Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022
4/29/2022
Grifols, S.A. announced that it has filed its 2021 Annual Report on Form 20-F with the United States Securities and Exchange Commission on April 29, 2022.